Molecular Characterization of Off-Target Activities of Telithromycin: a Potential Role for Nicotinic Acetylcholine Receptors
Open Access
- 1 December 2010
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (12), 5399-5402
- https://doi.org/10.1128/aac.00840-10
Abstract
Adverse effects have limited the clinical use of telithromycin. Preferential inhibition of the nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction (α3β2 and NMJ), the ciliary ganglion of the eye (α3β4 and α7), and the vagus nerve innervating the liver (α7) could account for the exacerbation of myasthenia gravis, the visual disturbance, and the liver failure seen with telithromycin use. The studies presented here enable the prediction of expected side effects of macrolides in development, such as solithromycin (CEM-101).Keywords
This publication has 10 references indexed in Scilit:
- Telithromycin blocks neuromuscular transmission and inhibits nAChR currents in vitroToxicology Letters, 2010
- Mammalian Nicotinic Acetylcholine Receptors: From Structure to FunctionPhysiological Reviews, 2009
- An automated system for intracellular and intranuclear injectionJournal of Neuroscience Methods, 2008
- Nicotinic Acetylcholine Receptors and Nicotinic Cholinergic Mechanisms of the Central Nervous SystemAnnual Review of Pharmacology and Toxicology, 2007
- Clinical Pharmacokinetics of Telithromycin, the First Ketolide AntibacterialClinical Pharmacokinetics, 2005
- Telithromycin and Myasthenia GravisClinical Infectious Diseases, 2003
- Distribution of azithromycin into brain tissue, cerebrospinal fluid, and aqueous humor of the eyeAntimicrobial Agents and Chemotherapy, 1996
- Immunohistochemical localization of neuronal nicotinic receptor subtypes at the pre- and postjunctional sites in mouse diaphragm muscleNeuroscience Letters, 1995